Abstract Lipopolysaccharide, a main co mponent of Gram-negative bacterial endotoxin is the lead ing cause of sepsis or endotoxic shock. This condition generates tissue hypoperfusion and leads to a state of acute metabolic-circulatory dysfunction and multio rgan systemic failure wh ich contributes to amplify the inflammatory response and resulting in the release of pro-inflammatory cytokines (TNF-α, IL-1 and IL-6). The effect of NutriSim© on serum pro-inflammatory cytokine concentrations were investigated in lipopolysaccharide-treated male W istar rats. Animals were rando mized into five groups: control groups receiv ing a single intraperitoneal in jection of physiologic saline solution or NutriSim© (10µl), respectively; LPS (20 mg/Kg, i.p.); NutriSim© treat ment 15 min before o r after LPS in the same aforementioned dose. The results showed that a single dose of NutriSim© prio r or before the endotoxic insult diminishes significantly the production of serum TNF-α, IL-1 and IL-6. Therefore NutriSim© can modulate an inflammatory response in experimental model of endotoxic shock.
Introduction
Endotoxic shock is a systemic response to a bacterial infection caused by endotoxins or lipopolysaccharide (LPS) [1] . LPS is a co mp lex glycolipid, composed of a hydrophilic polysaccharide mo iety and a hydrophobic domain known as lipid A, this is the toxic region of the mo lecule, and responsible fo r induction of immunostimu lat ory properties of LPS [2] . LPS is a major co mponent of the outer membrane of Gram-negative (GN) bacteria such as Escherichia coli, and one of the most potent microbial initiators of inflammat ion [3−5] .
Th e in flammato ry resp ons e to LPS is cru cial fo r protecting the host against pathogenic bacteria, nevertheless uncontrolled and excessive production of proinflammatory cytokines, such as tumo r necrosis factor-α (TNF-α), and interleukin (IL)-1, IL-6, IL-8, and IL-12 [6] can be harmful. Cytokines and other mediators may lead to serious systemic complications including microcircu latory dysfunction, liver and kidn ey d amage [7, 8] , and sept ic shock with a h igh mortality [9] .
NutriSim©, a nutritive supplement that contains arginine, lysine, choline, ammon iu m chloride, calciu m and magnesiu m is used empirically in the treatment of several degenerative disorders [10] . Prev iously, we have shown that NutriSim© p rotects against brain damage induced by ischemia -reperfusion in Mongolian gerbils. These effects are partly attributed to its antioxidant action [11] . Free rad icals are thought to be involved in the inflammatory process [12] , therefore in order to keep evaluating the potential of NutriSim©, the current study screened anti-inflammatory effect of that nutrit ive supplement on lipopolysaccharide-in duced cytokines production.
Materials and Methods

Materials (Reagents)
The lipopolysaccharide (LPS) of Escherichia coli, serotype 0111:B4 was purchased fro m Sig ma Chemical Co. 
Animals
Sixty adult male Wistar rats used for this research work were obtained fro m CIBO-IMSS (Guadalajara, Jalisco, Mexico). The animals weighed 200 -250 g, maintained on a 12h/12h light-dark cycle at (22 ± 2℃), fed with standard diet (Chow Purina) and water ad libitum.
Experi mental Design
Animals were randomly assigned to five experimental groups as shown below.
Group Control; treated with physiologic saline solution administered by intraperitoneal (i.p.) inject ion Group NutriSim©; received a single dose (10 µl/ 100g of body weight, i.p.) of NutriSim©.
Group LPS; received a LD100 dose of LPS (20mg/Kg of body weight, i.p.).
Gr oup LPS plus NutriSim©; received a LD100 dose of LPS (20mg/Kg of body weight, i.p.), 15 min befo re NutriSim©.
Group NutriSim© pl us LPS; NutriSim© was administered with a dose of NutriSim© (10 µl/ 100g of body weight, i.p.) 15 min before LPS.
Animals were sacrificed at 15, 30 and 60 min after the treatment; blood was collected immediately and centrifuged for 10 minutes, at 3000 rp m for co llect ion of seru m. Protein concentration was determined by the Bradford method using bovine serum albu min as a standard [13] .
Cytokines Quantifications (ELIS A)
TNF-α, IL-1β and IL-6 levels in the serum were quantified using commercially available ELISA kits specific for rat TNF-α (Genzy me, Cambridge, MA, USA), IL-1β and IL-6 (both fro m Endogen, Woburn, MA, USA). The sensitivity of the assays for TNF-α, IL-1β and IL-6 was 5 pg/ml, 12 pg/ml and 15 pg/ml, respectively. Absorbance at 405-414 n m was measured at a maximu m of 15 min after the addition of substrate, using a UV-Vis spectrophotometer (BIO-RAD 550).
Statistical Analysis
Statistical significance of d ifferences among groups was tested by one-way analysis of variance (ANOVA), followed by mu ltip le co mparisons between each group and control or other groups using Newman-Keuls t test; p ≤ 0.05 was considered significant.
Results
Serum Cytokines Levels
Basal levels of serum TNF-α, IL-1β and IL-6 were detected in saline-treated rats, respectively. Pre-t reatment of rats with NutriSim© alone did not affect the serum level of these cytokines (Figures 1-3) . The concentration of TNF-α in serum rapid ly increased, reaching a peak at 30 min after injection o f LPS, then dimin ishes. This increase was found to be statistically significant in comparison with the control group (p<0.01). NutriSim© prevents excessive expression of TNF-α in response to LPS (p <0.01), however the effect was higher when in jected prior LPS ad min istration (Figure 1 ). LPS challenge caused a marked rise in the level of IL-1β compared to control group; treatment with NutriSim© after and before the in jection of a LD100 of LPS dimin ishes significantly the serum IL-1β values during the course of the experiment (p<0.05). This was more ev ident at 60 minutes after LPS treat ment. (Figure 2) IL-6 release also occurred very rapidly and was significantly increased at 15 min, peaking at 30 min post-injection of LPS (P<0.01 vs. control). Experimental groups LPS plus NutriSim© and NutriSim© p lus LPS showed a significant decrease in the serum IL-6 concentration (p<0.01, Figure 3 ).
Discussion
We found that intraperitoneal ad ministration of lipopolysaccharide evoked a robust systemic response that induced a stereotypical cytokine release. Macrophages are target cells of LPS 14] . After interaction with an endotoxic bacterium, the innate immun ity is rapidly triggered, primarily via act ivation of toll-like receptor 4 (TLR-4) [15] . Activation of TLR-4 induces a multitude of pro inflammatory cytokines via activation of transcription factors, nuclear factor κB (NF-κB) [16] . This pro mpt response provides a favorable environment for the synthesis and upregulation of both IL-1β and IL-6, which together contribute to the perpetuation of the inflammatory challenge.
The pro-inflammatory response observed in septic shock is mediated by counter-regulatory molecules wh ich attempt to restore the immunological equilibriu m, amongst counter pro-in flammatory mo lecu les include TNF, IL-1; alternativel y, IL-10 an anti-in flammatory cytokine modulates the cascade and synthesis of inflammatory factors by ly mphocytes T and macrophages [17] .
Also the rapid increase in TNF-α following LPS, which is already present after 15 minutes, promotes synthesis of other cytokines and the initiat ion of the acute-phase response, chemokine release and oxidative stress [18] . Interestingly, the production of the reactive oxygen and nitrogen species is an inherent property of activated immune cells. Inflammation can lead to o xidative stress and conversely. Thus, oxidative stress and inflammation are involved in a self-perpetuating cycle. It is known that a deficiency of dietary amino acids impair immune functions, increasing the susceptibility to an infectious disease. The role of aminoacids such as arginine and lysine is very important in the immune response; they regulate the activation of T and B ly mphocytes, cellular redox status and production of cytokines [19] wh ich can be cytotoxic substances in pro-inflammatory process.
In this work we found that administration of NutriSim© 15 minutes prior or after LPS challenge dimin ishes significantly the level of seru m cytokines. Thus supplementation with a nutritional substance containing specific amino acids possibly enhances immune system response. On the other hand, anti-inflammatory effect could be due to L-argin ine, a semi-essential amino acid, wh ich has been describe to play an important role in stress situations like sepsis [20] . Additionally, it has been demonstrate that arginine diminishes lipid pero xidation in patients with diabetes mellitus [21] . It has been demonstrated that patients with severe sepsis shown low levels of arginine amongst others like citru lline and ornithine [22] . Th is could suggest that availability of argin ine supplementation could be useful as a probable potential therapeutic in cases on septic shock, though it hasn´t been demonstrated the relation between low levels of argin ine and severity of sepsis.
At this regard, it has been reported that natural antioxidants such as melatonin [23] , quercetin [24] , luteolin [25] and other antio xidants (butylated hydroxyanisole, tetrahydropapaveroline,nordihydroguiauretic acid, 10, 11-dihydro xyaporphine) [25] are potent inhibitors of the LPS-induced production of TNF-α production in vivo.
Choline is a precursor of neurotransmitter acetylcholine and an essential nutrient; it has also been demonstrated in vitro that choline inhib it TNF release in macrophages, and this might suggest that choline may be have anti-inflammatory activity [26] , although the efficiency of choline should be further investigated.
NutriSim© ad ministration in the absence of LPS does not altered the serum cytokines levels, which might suggest that this supplement does not exert a negative effect on the immune system.
Conclusions
It has been already demonstrated that LPS increase the cytokines production in immune cells and it can modulate both pro-and anti-inflammatory response; in this wo rk we demonstrate that the use of a nutritional supplement such as NutriSim©, can modulate an inflammatory response in experimental model of endotoxic shock. However, the mechanis m of action by which this supplement exerts its beneficial effect is still unclear. Whether our findings may be of therapeutic value needs to be further investigated.
